Human CRF2 α and β splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay
- 14 March 1999
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 38 (3) , 441-448
- https://doi.org/10.1016/s0028-3908(98)00201-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortinNeuropharmacology, 1997
- Interaction of [3H]Orphanin FQ and125I-Tyr14-Orphanin FQ with the Orphanin FQ Receptor: Kinetics and Modulation by Cations and Guanine NucleotidesMolecular Pharmacology, 1997
- Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's diseaseNature, 1995
- A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle.Proceedings of the National Academy of Sciences, 1995
- Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disordersPsychoneuroendocrinology, 1995
- Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A.Molecular and Cellular Biology, 1993
- Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.Proceedings of the National Academy of Sciences, 1992
- Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133Cell, 1989
- The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer.Proceedings of the National Academy of Sciences, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976